InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Ibrahim Ramy, Director. Officer active across 2 companies, notably bluebird bio, Inc.. Cumulatively, 8 disclosures have been published. History available since 15 June 2021. The latest transaction was disclosed on 13 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
8,400 shares0Common StockSEC:0001562180-23-005223:0
7,200 shares0Common StockSEC:0001562180-22-004995:0
00Common StockSEC:0001628280-21-023647:0
00Common StockSEC:0001628280-21-023647
1,448 shares0Common StockSEC:0001628280-21-023469:0
1,448 shares0Common StockSEC:0001628280-21-023469
3,109 shares0Common StockSEC:0001562180-21-004352
3,109 shares0Common StockSEC:0001562180-21-004352:0
8 of 8 declarations
About Ibrahim Ramy
Ramy Ibrahim is a Board Member at bluebird bio, Inc. and 2seventy bio, Inc. He provides valuable expertise to the board, contributing to the strategy and governance of these companies. His experience in the biopharmaceutical sector is an asset to bluebird bio and 2seventy bio.
